Showing results (31-40 of 652) with videos related to
Sort By:
Pageof 66
Revista Clinica Espanola|October 9, 2016
Ten years since the discovery of iPS cells: The current state of their clinical applicationJ Aznar, J TudelaHaemostasis|July 1, 1994
Role of plasminogen activator inhibitor type 1 in the pathogenesis of coronary artery diseasesJ Aznar, A EstellésRevista Clinica Espanola|July 7, 2012
Possible clinical usefulness of embryonic stem cellsJ Aznar, I GómezHaemostasis|January 1, 1978
Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation productE Regañon, J Aznar, V VilaThe Journal of Laboratory and Clinical Medicine|November 1, 1982
Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulinF Espana, J Aznar, A EstellesEnfermedades Infecciosas Y Microbiologia Clinica|April 1, 1991
[Evaluation of the Mycoscreen technique for the detection and quantification of genital mycoplasmas]A Pascual, M Arbeloa, J AznarScandinavian Journal of Haematology|February 1, 1976
Streptokinase resistance test in patients with streptococcal infection and/or high antistreptolysin titersJ Aznar, F Delgado, A EstellésThrombosis and Haemostasis|October 30, 1985
"Ex vivo" influence of fatty acids from plasma cholesterol and triglycerides on the fatty acid pattern of plateletsJ Aznar, T Santos, J VallésHaemostasis|January 1, 1984
Gelation of fibrinogen in plasma. A kinetic study by turbidity measurementE Regañon, V Vila, J AznarClinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 1978
Isolation of fibrin(ogen) degradation products from normal plasma by affinity chromatographic studyV Vila, E Regañon, J AznarPageof 66